Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2021 Filed Nov 22, 2021 11:05 UTC |
Kania EdwinDirector
|
GiftCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045464 · doc4.xml · nonDerivative · entry 4 KANIA EDWIN M JR · CIK 0001255927 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · OneLiberty Ventures, Inc. Disclosed balance after: 46,142 F5 · ownership.nature: Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of the OneLiberty Funds. Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 11:05 UTC |
Kania EdwinDirector
|
OtherCommon Stock | 25,234 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045464 · doc4.xml · nonDerivative · entry 2 KANIA EDWIN M JR · CIK 0001255927 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By OneLiberty Advisors Fund 2000, L.P. Disclosed balance after: 0 F2 · kind: On November 17, 2021, OneLiberty Advisors Fund 2000, L.P. ("OneLiberty Advisors 2000," together with OneLiberty 2000, the "OneLiberty Funds") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty GP, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended. F2 · price: On November 17, 2021, OneLiberty Advisors Fund 2000, L.P. ("OneLiberty Advisors 2000," together with OneLiberty 2000, the "OneLiberty Funds") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty GP, pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended. F5 · ownership.nature: Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of the OneLiberty Funds. Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 11:05 UTC |
Kania EdwinDirector
|
OtherCommon Stock | 779,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045464 · doc4.xml · nonDerivative · entry 1 KANIA EDWIN M JR · CIK 0001255927 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By OneLiberty Ventures 2000, L.P. Disclosed balance after: 0 F1 · kind: On November 17, 2021, OneLiberty Ventures Fund 2000, L.P. ("OneLiberty 2000") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty Partners 2000, LLC ("OneLiberty GP"), pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended. F1 · price: On November 17, 2021, OneLiberty Ventures Fund 2000, L.P. ("OneLiberty 2000") effected a distribution with respect to these shares to its limited partners and sole general partner, OneLiberty Partners 2000, LLC ("OneLiberty GP"), pro rata and without consideration. The aforementioned distribution was made in accordance with the exemptions afforded by Rule 16a-13 of the Securities Exchange Act, as amended. F5 · ownership.nature: Edwin M. Kania, Jr. is a manager of OneLiberty GP, which is the general partner of the OneLiberty Funds. Mr. Kania is also the principal of OneLiberty Ventures, Inc., which is the management company for, and provides services in connection with the investment activities of, the OneLiberty Funds. By virtue of the foregoing relationships, Mr. Kania may be deemed to indirectly beneficially own the securities held by OneLiberty GP, the OneLiberty Funds and OneLiberty Ventures, Inc., however he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:45 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-042421 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,273 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:45 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 1,680 | $28.16 | $47,308.80 |
DisclosureSEC source: 0000899243-21-042421 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $27.48 to $28.44, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:45 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-042421 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:52 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-039217 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,953 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:52 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 980 | $32.74 | $32,085.20 |
DisclosureSEC source: 0000899243-21-039217 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.37 to $33.12, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:52 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 700 | $31.76 | $22,232.00 |
DisclosureSEC source: 0000899243-21-039217 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $31.31 to $32.30, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:52 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-039217 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:34 UTC |
Provost MiriamVP of US Regulatory & FDA Rel.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-21-036415 · doc4.xml · derivative · entry 3 Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 5,625 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:34 UTC |
Provost MiriamVP of US Regulatory & FDA Rel.
|
SaleCommon Stock | 3,877 | $31.34 | $121,505.18 |
DisclosureSEC source: 0000899243-21-036415 · doc4.xml · nonDerivative · entry 2 Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,554 F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:34 UTC |
Provost MiriamVP of US Regulatory & FDA Rel.
|
Exercise / conversionCommon Stock | 5,625 | $16.14 | $90,787.50 |
DisclosureSEC source: 0000899243-21-036415 · doc4.xml · nonDerivative · entry 1 Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 18:25 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,941 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-035483 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,185 Underlying: Common Stock · 3,941 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 18:25 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 3,941 | $35.08 | $138,250.28 |
DisclosureSEC source: 0000899243-21-035483 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 18:25 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 3,941 | $0.28 | $1,103.48 |
DisclosureSEC source: 0000899243-21-035483 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 22:14 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0000899243-21-035480 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 22:14 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 10,000 | $35.00 | $350,000.00 |
DisclosureSEC source: 0000899243-21-035480 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 22:14 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.67 | $6,700.00 |
DisclosureSEC source: 0000899243-21-035480 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:14 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-035143 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,633 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:14 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 600 | $32.37 | $19,422.00 |
DisclosureSEC source: 0000899243-21-035143 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.29 to $32.60, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:14 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 1,080 | $31.77 | $34,311.60 |
DisclosureSEC source: 0000899243-21-035143 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $31.27 to $32.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:14 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-035143 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:04 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,200 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-034767 · doc4.xml · derivative · entry 2 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,772 Underlying: Common Stock · 3,200 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:04 UTC |
Sullivan John FVP of Quality & Engineering
|
Exercise / conversionCommon Stock | 3,200 | $0.28 | $896.00 |
DisclosureSEC source: 0000899243-21-034767 · doc4.xml · nonDerivative · entry 1 Sullivan John F · CIK 0001774273 · VP of Quality & Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 245 shares acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 21:05 UTC |
Godhani Rakesh P.Chief Digital Officer
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $27.87 | $0.00 |
DisclosureSEC source: 0000899243-21-031931 · doc4.xml · derivative · entry 1 Godhani Rakesh P. · CIK 0001876878 · Chief Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-08-04 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the Vesting Commencement Date, July 29, 2021, and as to the remaining shares in equal monthly installments over three years thereafter. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:00 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-031623 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,313 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:00 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 1,680 | $28.33 | $47,594.40 |
DisclosureSEC source: 0000899243-21-031623 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $28.54 to $29.14, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:00 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-031623 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 21:00 UTC |
Provost MiriamVP of US Regulatory & FDA Rel.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,206 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000899243-21-031299 · doc4.xml · derivative · entry 2 Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,765 Underlying: Common Stock · 2,206 shares Expires 2028-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 21:00 UTC |
Provost MiriamVP of US Regulatory & FDA Rel.
|
Exercise / conversionCommon Stock | 2,206 | $3.22 | $7,103.32 |
DisclosureSEC source: 0000899243-21-031299 · doc4.xml · nonDerivative · entry 1 Provost Miriam · CIK 0001773663 · VP of US Regulatory & FDA Rel. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 21:02 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0000899243-21-028668 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 21:02 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 10,000 | $35.00 | $350,000.00 |
DisclosureSEC source: 0000899243-21-028668 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 21:02 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.67 | $6,700.00 |
DisclosureSEC source: 0000899243-21-028668 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 18:35 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,152 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-028859 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,126 Underlying: Common Stock · 5,152 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 18:35 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 5,152 | $35.10 | $180,835.20 |
DisclosureSEC source: 0000899243-21-028859 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.25, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 18:35 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,152 | $0.28 | $1,442.56 |
DisclosureSEC source: 0000899243-21-028859 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:08 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-027478 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,993 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:08 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 200 | $34.05 | $6,810.00 |
DisclosureSEC source: 0000899243-21-027478 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.04 to $34.06, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:08 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 1,480 | $33.60 | $49,728.00 |
DisclosureSEC source: 0000899243-21-027478 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $33.02 to $34.00, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:08 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-027478 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 17:39 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,899 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-21-026595 · doc4.xml · derivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,278 Underlying: Common Stock · 3,899 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 17:39 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 3,899 | $35.06 | $136,698.94 |
DisclosureSEC source: 0000899243-21-026595 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,076 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.18, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 17:39 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 3,899 | $0.28 | $1,091.72 |
DisclosureSEC source: 0000899243-21-026595 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 21:08 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0000899243-21-025021 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 21:08 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 10,000 | $30.00 | $300,000.00 |
DisclosureSEC source: 0000899243-21-025021 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 21:08 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.67 | $6,650.00 |
DisclosureSEC source: 0000899243-21-025021 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:10 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,714 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0000899243-21-021820 · doc4.xml · derivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,999 Underlying: Common Stock · 5,714 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:10 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 5,714 | $0.67 | $3,828.38 |
DisclosureSEC source: 0000899243-21-021820 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:09 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-021819 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,673 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.